BioVie Inc. (BIVI)

BioVie Ratios and Metrics

Market cap in millions USD. Fiscal year is July - June.

Total Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 29, 2026	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Market Capitalization	12	15	17	24	156	36
Market Cap Growth	-17.57%	-14.70%	-29.93%	-84.35%	331.64%	-90.43%
Enterprise Value	3	2	-6	3	126	23
Last Close Price	1.54	1.94	9.25	40.05	431.00	145.00

Price Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 29, 2026	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
PB Ratio	1.13	1.43	0.90	1.58	10.19	9.87
P/TBV Ratio	1.17	1.47	0.93	1.66	10.89	14.73

Financial Efficiency

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 29, 2026	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Debt / Equity Ratio	0.03	0.03	0.02	0.39	0.94	3.34
Net Debt / Equity Ratio	-0.85	-0.85	-0.90	-1.14	-1.27	-1.74
Net Debt / EBITDA Ratio	0.39	0.39	0.96	0.56	0.44	0.24
Quick Ratio	2.93	2.93	8.64	2.55	2.34	4.47
Current Ratio	3.59	3.59	9.10	2.57	2.35	4.50
Return on Equity (ROE)	-150.76%	-150.76%	-101.64%	-208.26%	-528.70%	-598.18%
Return on Assets (ROA)	-79.06%	-79.06%	-48.28%	-66.69%	-102.05%	-130.22%
Return on Capital Employed (ROCE)	-216.70%	-216.70%	-93.70%	-202.90%	-218.70%	-170.90%

Yields

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 29, 2026	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Earnings Yield	-190.40%	-150.86%	-102.28%	-131.23%	-32.14%	-72.00%
Buyback Yield / Dilution	-390.46%	-390.46%	-226.96%	-39.10%	-31.71%	-98.84%

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Aug 13, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 29, 2026

Data Sources Report a data error